CeriBell, Inc.
$21.13
▲
0.38%
2026-04-21 05:55:00
www.ceribell.com
NMS: CBLL
Explore CeriBell, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$797.62 M
Current Price
$21.13
52W High / Low
$24.33 / $10.85
Stock P/E
—
Book Value
$4.14
Dividend Yield
—
ROCE
-33.07%
ROE
-30.83%
Face Value
—
EPS
$-1.46
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
327
Beta
—
Debt / Equity
14.34
Current Ratio
9.73
Quick Ratio
9.35
Forward P/E
-18.05
Price / Sales
7.67
Enterprise Value
$546.2 M
EV / EBITDA
-9.57
EV / Revenue
6.13
Rating
None
Target Price
$27.86
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | PAVmed Inc. | $9.44 | 150.27 | $60.26 M | — | -89.22% | -32.34% | $28.44 / $6 | $10.01 |
| 2. | LENSAR, Inc. | $5.55 | — | $71.73 M | — | -79.65% | -10.69% | $14.31 / $5.33 | $-2.17 |
| 3. | Bluejay Diagnostics, Inc. | $1.97 | — | $1.94 M | — | -115.88% | -1.17% | $16.68 / $1.65 | $9.88 |
| 4. | Phaos Technology Holdings (Caym | $1.95 | — | — | — | 214.51% | -10.73% | $7.39 / $0.53 | $-0.06 |
| 5. | Delcath Systems, Inc. | $10.88 | 139.76 | $377.34 M | — | 0.59% | 3% | $18.23 / $8.12 | $3.21 |
| 6. | Sight Sciences, Inc. | $4.36 | — | $220.88 M | — | -35.58% | -50.74% | $9.24 / $2.4 | $1.2 |
| 7. | Tivic Health Systems, Inc. | $1.13 | — | $3.25 M | — | -25.51% | -82.69% | $13.23 / $0.72 | $6.65 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 24.78 M | 22.59 M | 21.2 M | 20.49 M | 18.53 M | — |
| Operating Profit | -14.6 M | -14.65 M | -14.95 M | -14.21 M | -12.88 M | — |
| Net Profit | -13.53 M | -13.46 M | -13.64 M | -12.78 M | -12.58 M | — |
| EPS in Rs | -0.36 | -0.36 | -0.36 | -0.34 | -0.33 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 89.06 M | 65.44 M | 45.23 M | 25.92 M |
| Operating Profit | -58.4 M | -39.71 M | -30.04 M | -36.02 M |
| Net Profit | -53.41 M | -40.45 M | -29.46 M | -37.16 M |
| EPS in Rs | -1.42 | -1.07 | -0.78 | -0.99 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 195.8 M | 225.41 M | 58.92 M | 86.46 M |
| Total Liabilities | 40.47 M | 34.25 M | 171.17 M | 172.86 M |
| Equity | 155.34 M | 191.16 M | -112.25 M | -86.4 M |
| Current Assets | 186.72 M | 217.27 M | 51.96 M | 79.8 M |
| Current Liabilities | 19.19 M | 12.99 M | 21.6 M | 9.86 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -40.81 M | -35.04 M | -29.16 M | -32 M |
| Investing CF | -118.14 M | -1.6 M | -1.76 M | -1.4 M |
| Financing CF | 5.05 M | 196.52 M | -2.82 M | 49.8 M |
| Free CF | -41.58 M | -36.38 M | -30.14 M | -32.52 M |
| Capex | -0.77 M | -1.34 M | -0.98 M | -0.52 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 36.09% | 44.71% | 74.47% | — |
| Earnings Growth % | -32.03% | -37.3% | 20.72% | — |
| Profit Margin % | -59.97% | -61.82% | -65.15% | -143.37% |
| Operating Margin % | -65.57% | -60.68% | -66.43% | -138.96% |
| Gross Margin % | 87.89% | 86.72% | 84.38% | 82.91% |
| EBITDA Margin % | -56.34% | -57.03% | -58.61% | -135.26% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.